Press release
Prader-Willi Syndrome Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration and Companies by DelveInsight
Prader-Willi Syndrome Clinical Trials
Explore our latest breakthroughs in Prader Willi Syndrome Research. Learn more about our innovative pipeline today! @ Prader Willi Syndrome Pipeline Outlook- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Prader Willi Syndrome Pipeline Report
• In November 2024:- Harmony Biosciences LLC- A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome. The study will consist of an up to 45-day Screening/Baseline Period, a Double-Blind Treatment Period, and an optional Open-Label Extension Period.
• In November 2024:- ACADIA Pharmaceuticals- A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome. This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study comparing carbetocin nasal spray 3.2 mg TID with placebo (matched placebo nasal spray TID) in subjects with PWS.
• DelveInsight's Prader Willi Syndrome pipeline report depicts a robust space with 18+ active players working to develop 18+ pipeline therapies for Prader Willi Syndrome treatment.
• The leading Prader Willi Syndrome Companies such as Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.
• Promising Prader Willi Syndrome Therapies such as DCCR, ARD-101, Carbetocin, and others.
Stay informed about the cutting-edge advancements in Prader Willi Syndrome treatments. Download for updates and be a part of the revolution in care @ Prader Willi Syndrome Clinical Trials Assessment- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Prader Willi Syndrome Emerging Drugs Profile
• Diazoxide choline controlled release (DCCR): Soleno Therapeutics
Diazoxide choline controlled-release tablet is a novel, proprietary extended-release, crystalline salt formulation of diazoxide, which is administered once-daily. The parent molecule, diazoxide, has been used for decades in thousands of patients in a few rare diseases in neonates, infants, children and adults, but has not been approved for use in PWS. Soleno conceived of and established extensive patent protection on the therapeutic use of diazoxide and DCCR in patients with PWS. The DCCR development program is supported by data from five completed Phase I clinical studies in healthy volunteers and three completed Phase II clinical studies, one of which was in PWS patients. In the PWS Phase II study, DCCR showed promise in addressing hyperphagia, the hallmark symptom of PWS, as well as several other symptoms such as aggressive/destructive behaviors, fat mass and abnormal lipid profiles. It is currently in phase III stage of development.
• Intranasal carbetocin (LV-101): Levo Therapeutics
Intranasal carbetocin is similar to the naturally-occurring hormone oxytocin, but with greater selectivity for the effect of interest - stimulation of oxytocin receptors. These receptors are involved in the regulation of both social-emotional and feeding behaviors. In July 2022, company announced that the U.S. Food and Drug Administration (FDA) had granted Priority Review for its New Drug Application (NDA) for LV-101 (intranasal carbetocin) as a treatment for hyperphagia and behavioral distress associated with PWS.
Learn more about Prader Willi Syndrome Drugs opportunities in our groundbreaking Prader Willi Syndrome Research and development projects @ Prader Willi Syndrome Unmet Needs- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Prader Willi Syndrome Companies
Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.
Prader-Willi Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type
Prader Willi Syndrome Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Discover the latest advancements in Prader Willi Syndrome treatment by visiting our website. Stay informed about how we're transforming the future of disease @ Prader Willi Syndrome Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Prader Willi Syndrome Pipeline Report
• Coverage- Global
• Prader Willi Syndrome Companies- Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.
• Prader Willi Syndrome Therapies- DCCR, ARD-101, Carbetocin, and others.
• Prader Willi Syndrome Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Prader Willi Syndrome Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
For a detailed overview of our latest research findings and future plans, read the full details of Prader Willi Syndrome Pipeline on our website @ Prader Willi Syndrome Emerging Drugs and Companies- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Introduction
2. Executive Summary
3. Prader-Willi Syndrome: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. Diazoxide choline controlled release (DCCR): Soleno Therapeutics
8. Drug profiles in the detailed report…..
9. Mid Stage Products (Phase II)
10. Tesomet: Saniona
11. Drug profiles in the detailed report…..
12. Early Stage Products (Phase I)
13. INV 101: Inversago Pharma
14. Drug profiles in the detailed report…..
15. Preclinical and Discovery Stage Products
16. TNX-2900: Tonix Pharmaceuticals
17. Drug profiles in the detailed report…..
18. Inactive Products
19. Prader-Willi Syndrome Key Companies
20. Prader-Willi Syndrome Key Products
21. Prader-Willi Syndrome- Unmet Needs
22. Prader-Willi Syndrome- Market Drivers and Barriers
23. Prader-Willi Syndrome- Future Perspectives and Conclusion
24. Prader-Willi Syndrome Analyst Views
25. Prader-Willi Syndrome Key Companies
26. Appendix
Trending Reports:
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Aspergillosis Market: https://www.delveinsight.com/report-store/aspergillosis-market
• Atrophic Vaginitis Market: https://www.delveinsight.com/report-store/atrophic-vaginitis-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Autonomic Dysfunction Market: https://www.delveinsight.com/report-store/dysautonomia-autonomic-dysfunction-market
• Autosomal Recessive Congenital Ichthyosis Market Size: https://www.delveinsight.com/report-store/congenital-ichthyosis-market
• Bile Duct Neoplasm Market: https://www.delveinsight.com/report-store/bile-duct-cancer-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/report-store/bradycardia-treatment-devices-market
• Car T Therapy For Acute Lymphoblastic Leukemia All Market: https://www.delveinsight.com/report-store/car-t-cell-therapy-for-acute-lymphoblastic-leukemia-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
• Checkpoint Inhibitor Refractory Cancer Market: https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market
• Chondrosarcoma Market: https://www.delveinsight.com/report-store/chondrosarcoma-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Chronic Rhinosinusitis Phenotype With Nasal Polyps Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-phenotype-with-nasal-polyps-market-insight
• Clostridium Difficile Infections Cdi Market: https://www.delveinsight.com/report-store/clostridium-difficile-infections-clostridium-difficile-associated-disease-market
• Conference Coverage Services: https://www.delveinsight.com/consulting/conference-coverage-services
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Deep Vein Thrombosis Market: https://www.delveinsight.com/report-store/deep-vein-thrombosis-market
• Dermal Mycosis Market: https://www.delveinsight.com/report-store/dermal-mycosis-pipeline-insight
• Diabetic Nephropathy Market: https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prader-Willi Syndrome Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration and Companies by DelveInsight here
News-ID: 3807985 • Views: …
More Releases from DelveInsight Business Research
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease…
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product…
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical…
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth.
DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices…
More Releases for Syndrome
"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029.
Overview of the Rett Syndrome Market:
Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements…
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883
This latest report researches the industry structure, sales, revenue,…
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440
This latest report researches the industry structure, sales, revenue,…
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which…
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which…
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and…
